American International Group, Inc. Reneo Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.59 - $1.74 $190 - $208	-120 Reduced 1.86%	6,330 $10,000
Q4 2023 Feb 13, 2024	SELL	$1.34 - $8.43 $34 - $219	-26 Reduced 0.4%	6,450 $10,000
Q3 2023 Nov 13, 2023	BUY	$5.44 - $8.13 $9,884 - $14,772	1,817 Added 39.0%	6,476 $49,000
Q2 2023 Aug 04, 2023	BUY	$5.44 - $10.5 $25,344 - $48,919	4,659 New	4,659 $30,000
Q2 2022 Aug 12, 2022	SELL	$1.96 - $3.04 $8,459 - $13,120	-4,316 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.94 - $9.07 $890 - $2,748	-303 Reduced 6.56%	4,316 $13,000
Q4 2021 Feb 11, 2022	BUY	$6.07 - $9.68 $7,083 - $11,296	1,167 Added 33.81%	4,619 $39,000
Q3 2021 Nov 12, 2021	SELL	$6.28 - $11.07 $514 - $907	-82 Reduced 2.32%	3,452 $26,000
Q2 2021 Aug 13, 2021	BUY	$7.78 - $15.0 $27,494 - $53,010	3,534 New	3,534 $33,000

31M

50.8K

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.